PHARMANUTRA SPA (PHN.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:PHN - IT0005274094 - Common Stock
50.1 EUR
+0.1 (+0.2%)
Taking everything into account, PHN scores 7 out of 10 in our fundamental rating. PHN was compared to 15 industry peers in the Personal Care Products industry. Both the health and profitability get an excellent rating, making PHN a very profitable company, without any liquidiy or solvency issues. PHN is valued quite expensive, but it does show an excellent growth. This makes PHN very considerable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year PHN was profitable.
PHN had a positive operating cash flow in the past year.
Each year in the past 5 years PHN has been profitable.
PHN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
PHN has a better Return On Assets (20.41%) than 100.00% of its industry peers.
PHN has a Return On Equity of 38.54%. This is amongst the best in the industry. PHN outperforms 100.00% of its industry peers.
PHN has a Return On Invested Capital of 26.24%. This is amongst the best in the industry. PHN outperforms 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PHN is significantly above the industry average of 11.66%.
The 3 year average ROIC (17.21%) for PHN is below the current ROIC(26.24%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.41% | ||
| ROE | 38.54% | ||
| ROIC | 26.24% |
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
1.3 Margins
Looking at the Profit Margin, with a value of 13.48%, PHN is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
In the last couple of years the Profit Margin of PHN has declined.
Looking at the Operating Margin, with a value of 21.87%, PHN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
PHN's Operating Margin has been stable in the last couple of years.
PHN's Gross Margin of 97.04% is amongst the best of the industry. PHN outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of PHN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.87% | ||
| PM (TTM) | 13.48% | ||
| GM | 97.04% |
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PHN is creating value.
PHN has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for PHN has been reduced compared to 5 years ago.
Compared to 1 year ago, PHN has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 9.09 indicates that PHN is not in any danger for bankruptcy at the moment.
PHN's Altman-Z score of 9.09 is amongst the best of the industry. PHN outperforms 100.00% of its industry peers.
The Debt to FCF ratio of PHN is 2.70, which is a good value as it means it would take PHN, 2.70 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of PHN (2.70) is better than 73.33% of its industry peers.
A Debt/Equity ratio of 0.28 indicates that PHN is not too dependend on debt financing.
The Debt to Equity ratio of PHN (0.28) is better than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.28 | ||
| Debt/FCF | 2.7 | ||
| Altman-Z | 9.09 |
ROIC/WACC3.35
WACC7.82%
2.3 Liquidity
A Current Ratio of 2.06 indicates that PHN has no problem at all paying its short term obligations.
PHN has a Current ratio of 2.06. This is amongst the best in the industry. PHN outperforms 93.33% of its industry peers.
PHN has a Quick Ratio of 1.75. This is a normal value and indicates that PHN is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.75, PHN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.06 | ||
| Quick Ratio | 1.75 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 20.20% over the past year.
Measured over the past years, PHN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.63% on average per year.
Looking at the last year, PHN shows a quite strong growth in Revenue. The Revenue has grown by 15.06% in the last year.
The Revenue has been growing by 16.59% on average over the past years. This is quite good.
EPS 1Y (TTM)20.2%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%3.36%
Revenue 1Y (TTM)15.06%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%10.35%
3.2 Future
PHN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.67% yearly.
PHN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.07% yearly.
EPS Next Y5.49%
EPS Next 2Y12.76%
EPS Next 3Y14.67%
EPS Next 5YN/A
Revenue Next Year14.06%
Revenue Next 2Y14.68%
Revenue Next 3Y15.27%
Revenue Next 5Y14.07%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 20.45, PHN is valued on the expensive side.
Based on the Price/Earnings ratio, PHN is valued a bit cheaper than 73.33% of the companies in the same industry.
When comparing the Price/Earnings ratio of PHN to the average of the S&P500 Index (25.47), we can say PHN is valued inline with the index average.
The Price/Forward Earnings ratio is 20.71, which indicates a rather expensive current valuation of PHN.
66.67% of the companies in the same industry are cheaper than PHN, based on the Price/Forward Earnings ratio.
PHN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 34.42.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.45 | ||
| Fwd PE | 20.71 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHN is on the same level as its industry peers.
PHN's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. PHN is more expensive than 73.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 59.21 | ||
| EV/EBITDA | 11.39 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PHN does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of PHN may justify a higher PE ratio.
PHN's earnings are expected to grow with 14.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.73
PEG (5Y)1.4
EPS Next 2Y12.76%
EPS Next 3Y14.67%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.00%, PHN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.02, PHN has a dividend in line with its industry peers.
PHN's Dividend Yield is comparable with the S&P500 average which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2% |
5.2 History
On average, the dividend of PHN grows each year by 11.21%, which is quite nice.
Dividend Growth(5Y)11.21%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
40.63% of the earnings are spent on dividend by PHN. This is a bit on the high side, but may be sustainable.
PHN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP40.63%
EPS Next 2Y12.76%
EPS Next 3Y14.67%
BIT:PHN (11/21/2025, 5:29:39 PM)
50.1
+0.1 (+0.2%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners17.08%
Inst Owner ChangeN/A
Ins Owners65.02%
Ins Owner ChangeN/A
Market Cap484.97M
Revenue(TTM)175.08M
Net Income(TTM)23.61M
Analysts82.86
Price Target82.62 (64.91%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2% |
Yearly Dividend0.85
Dividend Growth(5Y)11.21%
DP40.63%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.53%
PT rev (3m)2.53%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3.09%
EPS NY rev (3m)-9.42%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.45 | ||
| Fwd PE | 20.71 | ||
| P/S | 2.77 | ||
| P/FCF | 59.21 | ||
| P/OCF | 39.35 | ||
| P/B | 7.92 | ||
| P/tB | 12.99 | ||
| EV/EBITDA | 11.39 |
EPS(TTM)2.45
EY4.89%
EPS(NY)2.42
Fwd EY4.83%
FCF(TTM)0.85
FCFY1.69%
OCF(TTM)1.27
OCFY2.54%
SpS18.09
BVpS6.33
TBVpS3.86
PEG (NY)3.73
PEG (5Y)1.4
Graham Number18.68
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.41% | ||
| ROE | 38.54% | ||
| ROCE | 45.24% | ||
| ROIC | 26.24% | ||
| ROICexc | 32.19% | ||
| ROICexgc | 49.25% | ||
| OM | 21.87% | ||
| PM (TTM) | 13.48% | ||
| GM | 97.04% | ||
| FCFM | 4.68% |
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
ROICexc(3y)25.61%
ROICexc(5y)33.67%
ROICexgc(3y)43.23%
ROICexgc(5y)50.61%
ROCE(3y)29.76%
ROCE(5y)31.61%
ROICexgc growth 3Y-15.98%
ROICexgc growth 5Y-10.26%
ROICexc growth 3Y-20.69%
ROICexc growth 5Y-11.75%
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
F-Score7
Asset Turnover1.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.28 | ||
| Debt/FCF | 2.7 | ||
| Debt/EBITDA | 0.4 | ||
| Cap/Depr | 97.13% | ||
| Cap/Sales | 2.36% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 28.97% | ||
| Profit Quality | 34.7% | ||
| Current Ratio | 2.06 | ||
| Quick Ratio | 1.75 | ||
| Altman-Z | 9.09 |
F-Score7
WACC7.82%
ROIC/WACC3.35
Cap/Depr(3y)763.09%
Cap/Depr(5y)544.05%
Cap/Sales(3y)14.97%
Cap/Sales(5y)11.04%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.2%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%3.36%
EPS Next Y5.49%
EPS Next 2Y12.76%
EPS Next 3Y14.67%
EPS Next 5YN/A
Revenue 1Y (TTM)15.06%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%10.35%
Revenue Next Year14.06%
Revenue Next 2Y14.68%
Revenue Next 3Y15.27%
Revenue Next 5Y14.07%
EBIT growth 1Y14.83%
EBIT growth 3Y13.47%
EBIT growth 5Y17.77%
EBIT Next Year22.06%
EBIT Next 3Y16.37%
EBIT Next 5Y9.97%
FCF growth 1Y144.25%
FCF growth 3Y1.75%
FCF growth 5Y17.94%
OCF growth 1Y38.33%
OCF growth 3Y0.14%
OCF growth 5Y11.34%
PHARMANUTRA SPA / PHN.MI FAQ
What is the fundamental rating for PHN stock?
ChartMill assigns a fundamental rating of 7 / 10 to PHN.MI.
What is the valuation status for PHN stock?
ChartMill assigns a valuation rating of 3 / 10 to PHARMANUTRA SPA (PHN.MI). This can be considered as Overvalued.
How profitable is PHARMANUTRA SPA (PHN.MI) stock?
PHARMANUTRA SPA (PHN.MI) has a profitability rating of 8 / 10.
Can you provide the financial health for PHN stock?
The financial health rating of PHARMANUTRA SPA (PHN.MI) is 8 / 10.
How sustainable is the dividend of PHARMANUTRA SPA (PHN.MI) stock?
The dividend rating of PHARMANUTRA SPA (PHN.MI) is 5 / 10 and the dividend payout ratio is 40.63%.